Variant report
Variant | nsv966953 |
---|---|
Chromosome Location | chr3:120809440-120824854 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:120822725-120822791 | IMR90 | lung: | n/a | n/a |
2 | CEBPB | chr3:120822664-120822845 | HepG2 | liver: | n/a | n/a |
3 | CTCF | chr3:120813164-120813221 | Lung_OC | lung: | n/a | n/a |
4 | FOXA1 | chr3:120815836-120816170 | HepG2 | liver: | n/a | n/a |
5 | FOXA1 | chr3:120815864-120816162 | T-47D | breast: | n/a | n/a |
6 | FOXA1 | chr3:120815820-120816076 | HepG2 | liver: | n/a | n/a |
7 | FOXA1 | chr3:120815822-120816200 | HepG2 | liver: | n/a | n/a |
8 | FOXA1 | chr3:120815796-120816167 | T-47D | breast: | n/a | n/a |
9 | FOXA1 | chr3:120815857-120816191 | HepG2 | liver: | n/a | n/a |
10 | FOXA2 | chr3:120815784-120816156 | A549 | lung: | n/a | n/a |
11 | FOXA2 | chr3:120815820-120816044 | HepG2 | liver: | n/a | n/a |
12 | FOXA2 | chr3:120815897-120816220 | A549 | lung: | n/a | n/a |
13 | POLR2A | chr3:120815979-120816144 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | POLR2A | chr3:120816030-120816033 | A549 | lung: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GTF2E1-4 | chr3:120817955-120818621 | NONHSAT091470 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000243813 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548855179 | chr3:120813177-120813178 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs139671819 | chr3:120813178-120813179 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs146907630 | chr3:120813191-120813192 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs551412646 | chr3:120813201-120813202 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs571536707 | chr3:120813211-120813212 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs537370963 | chr3:120813215-120813216 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs368664432 | chr3:120815200-120815201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539924428 | chr3:120815232-120815233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533885526 | chr3:120815236-120815237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375946529 | chr3:120815249-120815250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533258350 | chr3:120815269-120815270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533280714 | chr3:120815280-120815281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540179579 | chr3:120815286-120815287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115544675 | chr3:120815287-120815288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539009507 | chr3:120815294-120815295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185378619 | chr3:120815312-120815313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368282523 | chr3:120815314-120815315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142558331 | chr3:120815318-120815319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7648200 | chr3:120815348-120815349 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs13060148 | chr3:120815365-120815366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572099449 | chr3:120815382-120815383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541237513 | chr3:120815405-120815406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564537585 | chr3:120815408-120815409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189495214 | chr3:120815415-120815416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375187332 | chr3:120815421-120815422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7648217 | chr3:120815424-120815425 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs563569977 | chr3:120815440-120815441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372975686 | chr3:120815441-120815442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376960742 | chr3:120815467-120815468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147578830 | chr3:120815475-120815476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192194318 | chr3:120815488-120815489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529569747 | chr3:120815492-120815493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559997049 | chr3:120815500-120815501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs55735561 | chr3:120815508-120815509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551571893 | chr3:120815511-120815512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570181857 | chr3:120815529-120815530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569114642 | chr3:120815533-120815534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184975967 | chr3:120815534-120815535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188466761 | chr3:120815535-120815536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs72956027 | chr3:120815556-120815557 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs535735078 | chr3:120815561-120815562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144174371 | chr3:120815571-120815572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565982336 | chr3:120815587-120815588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113204177 | chr3:120815608-120815609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147961601 | chr3:120815668-120815669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140591613 | chr3:120815690-120815691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543977344 | chr3:120815700-120815701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181657447 | chr3:120815741-120815742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7648612 | chr3:120815781-120815782 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs7637100 | chr3:120815806-120815807 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Developmental delay | 22180640 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Autism | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:120815200-120816400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:120815400-120815800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr3:120815600-120816000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr3:120815600-120816000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr3:120815800-120816200 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr3:120815800-120816200 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr3:120816400-120816600 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr3:120816600-120817200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
9 | chr3:120817600-120817800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |